# Amgen Inc: Form 8-K, filed Oct 6, 2023

- Company: [Amgen Inc](/companies/amgn.md) (CIK 318154)
- Form: 8-K
- Filed: 2023-10-06
- Accepted by EDGAR: Oct 6, 2023, 16:01 ET
- Period: 2023-10-06
- Accession: 0001193125-23-252361
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/318154/000119312523252361/d534754d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/318154/000119312523252361/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 2.03: New direct financial obligation
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/318154/000119312523252361/d534754d8k.htm

Filed Oct 6, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-252361. Last ingested by Listed: Nov 10, 2026, 06:19 ET. No prices; not investment advice.
